Traders digested weaker-than-expected quarterly results from Google-parent Alphabet.

While the company beat revenue and profit estimates, slower growth at the Azure cloud business appears to be weighing on the stock.

Stocks gained on Tuesday for a third consecutive trading session, buoyed in part by a decline in bond yields and a weaker dollar.

The Clorox Co. is recalling certain Pine-Sol cleaning products in connection to bacteria exposure risk, the Consumer Product Safety Commission said Tuesday.

Tightening markets for liquefied natural gas (LNG) worldwide and major oil producers cutting supply have put the world in the middle of "the first truly global energy crisis", the head of the International Energy Agency (IEA) said on Tuesday.

Spotify shares fell in extended trading Tuesday after reporting a third-quarter loss that was wider than analyst expectations.

Chipotle reported its Q3 earnings after the market close on Tuesday.

"Meta has drifted into the land of excess."

Big drops in San Diego, Los Angeles, Dallas, Portland, Phoenix, Boston. Prices going down faster than they’d spiked? No way. Oops.

Outlook for the new fiscal year doesn't bake in recession scenario, but CFO says company will stay 'vigilant'

A record number of American households had bank accounts in 2021, according to a survey released Tuesday by the Federal Deposit Insurance Corporation.

Ethereum Classic (CRYPTO: ETC) is trading higher by some 12.29% to $29.47 during Tuesday afternoon.

A monthly gauge of the economy that's used to signal what's ahead was down in September by 2.8% from six months earlier, but not all the data used is bad.

"We are moving from a market that was suffering from significant excess demand to one where there is a risk of modest excess supply," ING said.

"Is Twitter dying?" billionaire Elon Musk mused in April, five days before offering to buy the social media platform.

Amid higher costs and market volatility, the amount of money people think they will need to retirement comfortably has increased 20% since last year.

U.S. consumer confidence ebbed in October after two straight monthly increases amid rising concerns about inflation and a possible recession next year, but households remained keen to purchase big-ticket items like motor vehicles and appliances.

The FDA on Tuesday granted accelerated approval to Johnson & Johnson's Tecvayli (teclistamab), a BCMA-directed bispecific antibody, looking to head into an already crowded field of treatments aiming to help those with the blood cancer multiple myeloma. The ap…